Skip to main content

Tiba Aynechi, Ph.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when MBX Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get MBX alerts

About Tiba Aynechi, Ph.D.

Tiba Aynechi, Ph.D. is recorded as Board Member at MBX Biosciences, Inc. (MBX) since June 5, 2025. Spruce Biosciences, Inc. reported in an 8-K filed December 12, 2025 that Tiba Aynechi, Ph.D. resigned as member of the board of directors, effective December 11, 2025. MBX Biosciences, Inc. reported in an 8-K filed June 6, 2025 that Tiba Aynechi, Ph.D. was appointed Class I director, effective June 5, 2025. MBX Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at MBX Biosciences, Inc. includes Steven Hoerter (CEO and Chairman), John Smither (CFO), Ed Mathers (Board Member) and 7 others.

“On December 11, 2025, Tiba Aynechi, Ph.D. notified Spruce Biosciences, Inc. (the "Company") of her resignation as a member of the board of directors (the "Board") of the Company and as the Chair of the Compensation Committee of the Board (the "Compensation Committee"), effective immediately.”
Spruce Biosciences, Inc. Form 8-K, filed December 12, 2025 · Read the filing
“to elect two Class I director nominees, Tiba Aynechi, Ph.D. and P. Kent Hawryluk, to the Company's Board of Directors, each to hold office until the Company's 2028 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal”
MBX Biosciences, Inc. Form 8-K, filed June 6, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at MBX Biosciences, Inc.

Recent activity